Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2007-04-10
2008-11-04
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C435S006120
Reexamination Certificate
active
07445786
ABSTRACT:
Composition for conferring protection againstTursiops truncatuspapillomavirus (TtPV) infection in a subject includes a virus-like particle assembled from at least one type of TtPV L1 protein. Methods for protecting a subject against TtPV infection include administering to the subject an immunogenic composition including a virus-like particle assembled from at least one type of TtPV L1 protein. Methods for diagnosing TtPV infection in a subject include providing a virus-like particle assembled from at least one TtPV L1 protein; contacting the virus-like particle with serum obtained from the subject; and identifying the subject as having TtPV infection if a TtPV antibody capable of binding the virus-like particle is detected in the serum.
REFERENCES:
patent: 5057411 (1991-10-01), Lancaster et al.
patent: 5283171 (1994-02-01), Manos et al.
patent: 5639606 (1997-06-01), Willey
patent: 5643765 (1997-07-01), Willey
patent: 5874089 (1999-02-01), Schlegel et al.
patent: 6153201 (2000-11-01), Rose et al.
patent: 6165471 (2000-12-01), Garcea et al.
patent: 6485728 (2002-11-01), Schlegel et al.
patent: 6887478 (2005-05-01), Schlegel et al.
patent: 6908615 (2005-06-01), Hofmann et al.
patent: 7001995 (2006-02-01), Neeper et al.
patent: 2002/0197264 (2002-12-01), Schlegel et al.
patent: 2004/0086527 (2004-05-01), Schlegel et al.
patent: 2005/0026257 (2005-02-01), Gissmann et al.
patent: 2005/0282263 (2005-12-01), McCormick et al.
patent: 2006/0029612 (2006-02-01), Palmer et al.
Rehtanz et al., “Isolation and characterization of the first American bottlenose dolphin papillomavirus:Tursiops truncatuspapillomavirus type 2”, Journal of General Virology, 87, 2006, pp. 3559-3565.
Bossart et al., “Cutaneous papovaviral-like papillomatosis in a killer whale (Orcinus orca)”, Mar. Mamm. Sci., 12, 2006, pp. 274-281.
Bossart et al., “Viral papillomatosis in Florida manatees (Trichechus manatus latirostris)”, Exp. Mol. Pathol., 72, 2002, pp. 37-48.
Bossart et al., “Orogenital neoplasia in Atlantic bottlenose dolphins (Tursiops truncates)”, Aquatic Mammals, 31(4), 2005, pp. 473-480.
Ghim et al., “Equine papillomavirus type 1: complete nucleotide sequence and characterization of recombinant virus-like particles composed of the EcPV-1 L1 major capsid protein”, Bioch. Biophys. Res. Commun., 324(3), 2004, pp. 1108-1115.
Jenson et al. “Multiplicity of Uses of Monoclonal Antibodies That Define Papillomavirus Linear Immunodominant Epitopes”, Immunol. Res., 16, 1997, pp. 115-119.
Lambertsen et al., “Genital papillomatosis in sperm whale bulls”, J.Zoo Wildl. Med., 23, 1997, pp. 374-379.
Pastrana et al., “Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2”, Virology, 337, 2005, pp. 365-372.
Rector et al., “Characterization of a Novel Close-to-Root Papillomavirus from a Florida Manatee by Using Multiply Primed Rolling-Circle Amplification:Trichechus manatus latirostrisPapillomavirus Type 1”, J. Virol., 78, 2004, pp. 12698-12702.
Van Bressem et al., “Genital and lingual warts in small cetaceans from coastal Peru”, Dis. Aquat. Org., 26, 1996, pp. 1-10.
Van Bressem, M. F., “Natural history of virus infections in cetaceans”, PhD thesis, University off Liège, 1997.
Van Bressem et al., Cutaneous papillomavirus infection in harbour porpoise (Phocoena phocoena) from the North Sea, Vet. Rec., 144, 1999a, pp. 592-593.
Van Bressem et al., “A review of virus infections of cetaceans and the potential impact of morbilliviruses, poxviruses and papillomaviruses on host population dynamics”, Dis. Aquat. Org., 38, 1999b, pp. 53-65.
Jenson et al., “Immunologic relatedness of papillomaviruses from different species”, Journal of the National Cancer Institute, 64, 1980, pp. 495-500.
Yuan, et al., “An epidermotropic canine papillomavirus with malignant potential contains an E5 gene and establishes a unique genus”, Virology, 359, 2007; pp. 28-36.
Ghim et al., “Cervical cancer, etiology, pathogenesis treatment and future vaccines”, Asian Pacific Journal of Cancer Prevention, 3, 2002, pp. 207-214.
Nakai et al., “Monoclonal Antibodies to Genus- and Type-Specific Papillomavirus Structural Antigens”, Intervirology, 25, 1986, pp. 30-37.
Bossart Gregory D.
Ghim Shin-je
Jenson A. Bennett
Rehtanz Manuela
Decker Mandy Wilson
Salimi Ali R.
Stites & Harbison PLLC
LandOfFree
Diagnosing and protecting against tursiops truncatus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosing and protecting against tursiops truncatus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosing and protecting against tursiops truncatus... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4021814